跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEPTO-BISMOL EXTRA CAPLET - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PEPTO-BISMOL EXTRA CAPLET
Authorized
STANDARD
PEPTO-BISMOL EXTRA CAPLET
procter & gamble inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6e8ce2749dbe8b3b
Company
procter & gamble inc
Type
Standard
Approval Details
Approval Id
6e8ce2749dbe8b3b
Drug Approval Canada Name
PEPTO-BISMOL EXTRA CAPLET
Product Name
PEPTO-BISMOL EXTRA CAPLET
Status
Marketed
Status Date
2023-11-12
Original Market Date
2023-11-12
Din
02530759
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
OTC
Ahfs
56:08.00
Atc Original
A07BB BISMUTH PREPARATIONS
Atc Name
a 07 bb
Aig Number
0111864006
Company Name
procter & gamble inc
Company Address
5160 Yonge Stree 14th Floor P.O. Box 355 Station A, Toronto, Ontario, Canada, M5W 1C5
Active Ingredients
BISMUTH SUBSALICYLATE
524 MG / TAB
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6e8ce2749dbe8b3b
Type
Standard
Back to Health Canada Approvals